These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37493451)

  • 21. The opposing effects of endothelin-1 and C-type natriuretic peptide on apoptosis of neonatal rat cardiac myocytes.
    Han B; Fixler R; Beeri R; Wang Y; Bachrach U; Hasin Y
    Eur J Pharmacol; 2003 Aug; 474(1):15-20. PubMed ID: 12909191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.
    de Lange WJ; Farrell ET; Kreitzer CR; Jacobs DR; Lang D; Glukhov AV; Ralphe JC
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1670-H1686. PubMed ID: 33606581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes.
    Del Ry S; Cabiati M; Vozzi F; Battolla B; Caselli C; Forini F; Segnani C; Prescimone T; Giannessi D; Mattii L
    Peptides; 2011 Aug; 32(8):1713-8. PubMed ID: 21723350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic evaluation of isometric contraction-relaxation coupling indexes in rabbit ventricular muscle.
    Baudet S; Noireaud J
    J Pharmacol Toxicol Methods; 1999 Sep; 42(1):21-30. PubMed ID: 10715600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts.
    Su J; Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1367-73. PubMed ID: 15550520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart.
    Yasoda A
    Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortin induces positive inotropic effect in rat heart.
    Calderón-Sanchez E; Delgado C; Ruiz-Hurtado G; Domínguez-Rodríguez A; Cachofeiro V; Rodríguez-Moyano M; Gomez AM; Ordóñez A; Smani T
    Cardiovasc Res; 2009 Sep; 83(4):717-25. PubMed ID: 19460778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
    Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
    Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
    Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries.
    Kun A; Kiraly I; Pataricza J; Marton Z; Krassoi I; Varro A; Simonsen U; Papp JG; Pajor L
    J Sex Med; 2008 May; 5(5):1114-1125. PubMed ID: 18312283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae.
    Mannhardt I; Eder A; Dumotier B; Prondzynski M; Krämer E; Traebert M; Söhren KD; Flenner F; Stathopoulou K; Lemoine MD; Carrier L; Christ T; Eschenhagen T; Hansen A
    Toxicol Sci; 2017 Jul; 158(1):164-175. PubMed ID: 28453742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular relaxation induced by C-type natriuretic peptide involves the ca2+/NO-synthase/NO pathway.
    Andrade FA; Restini CB; Grando MD; Ramalho LN; Bendhack LM
    PLoS One; 2014; 9(5):e95446. PubMed ID: 24787693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
    Tokudome T; Horio T; Soeki T; Mori K; Kishimoto I; Suga S; Yoshihara F; Kawano Y; Kohno M; Kangawa K
    Endocrinology; 2004 May; 145(5):2131-40. PubMed ID: 14749356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-type natriuretic peptide induces human colonic myofibroblast relaxation.
    Chitapanarux T; Chen SL; Lee H; Melton AC; Yee HF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G31-6. PubMed ID: 12958024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
    Soeki T; Kishimoto I; Okumura H; Tokudome T; Horio T; Mori K; Kangawa K
    J Am Coll Cardiol; 2005 Feb; 45(4):608-16. PubMed ID: 15708711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
    Horio T; Tokudome T; Maki T; Yoshihara F; Suga S; Nishikimi T; Kojima M; Kawano Y; Kangawa K
    Endocrinology; 2003 Jun; 144(6):2279-84. PubMed ID: 12746286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.
    Cachorro E; Günscht M; Schubert M; Sadek MS; Siegert J; Dutt F; Bauermeister C; Quickert S; Berning H; Nowakowski F; Lämmle S; Firneburg R; Luo X; Künzel SR; Klapproth E; Mirtschink P; Mayr M; Dewenter M; Vettel C; Heijman J; Lorenz K; Guan K; El-Armouche A; Wagner M; Kämmerer S
    Circ Res; 2023 Feb; 132(4):400-414. PubMed ID: 36715019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
    Iseoka H; Miyagawa S; Fukushima S; Saito A; Masuda S; Yajima S; Ito E; Sougawa N; Takeda M; Harada A; Lee JK; Sawa Y
    Tissue Eng Part A; 2018 Feb; 24(3-4):287-300. PubMed ID: 28498040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery.
    Feric NT; Pallotta I; Singh R; Bogdanowicz DR; Gustilo MM; Chaudhary KW; Willette RN; Chendrimada TP; Xu X; Graziano MP; Aschar-Sobbi R
    Toxicol Sci; 2019 Nov; 172(1):89-97. PubMed ID: 31385592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethylamine-
    Oakley CI; Vallejo JA; Wang D; Gray MA; Tiede-Lewis LM; Shawgo T; Daon E; Zorn G; Stubbs JR; Wacker MJ
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1272-H1282. PubMed ID: 32243768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.